MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 108 filers reported holding MYOVANT SCIENCES LTD in Q3 2020. The put-call ratio across all filers is 1.27 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $389,000 | -73.3% | 25,000 | -61.5% | 0.11% | -74.2% |
| Q3 2021 | $1,459,000 | -24.6% | 65,000 | -23.5% | 0.42% | -21.4% |
| Q2 2021 | $1,935,000 | +44.6% | 85,000 | +30.8% | 0.53% | +39.5% |
| Q1 2021 | $1,338,000 | -3.1% | 65,000 | +30.0% | 0.38% | -7.1% |
| Q4 2020 | $1,381,000 | +96.4% | 50,000 | 0.0% | 0.41% | +91.2% |
| Q3 2020 | $703,000 | – | 50,000 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 3,474,645 | $71,647,000 | 83.05% |
| VR Adviser, LLC | 845,000 | $17,424,000 | 4.17% |
| Opaleye Management Inc. | 682,500 | $14,073,000 | 2.84% |
| Eversept Partners, LP | 760,551 | $15,682,562 | 2.15% |
| Cormorant Asset Management, LP | 2,500,000 | $51,550,000 | 1.97% |
| Ghost Tree Capital, LLC | 300,000 | $6,186,000 | 1.63% |
| Bellevue Group AG | 4,647,000 | $95,821,000 | 1.36% |
| Aristides Capital LLC | 67,000 | $1,382,000 | 1.04% |
| Amia Capital LLP | 27,070 | $558,000 | 0.46% |
| Rhenman & Partners Asset Management AB | 150,000 | $3,093,000 | 0.33% |